CYNAERA ESA™ Leveraging Local Clinics as Micro-ERs During Disasters
- 2 days ago
- 15 min read
Executive summary
Each hurricane and flood season reveals the same systemic failure: emergency departments are overwhelmed by patients who could have been safely and effectively stabilized at local urgent care centers or community clinics. These patients often require only basic interventions—IV fluids, oxygen, and antihistamines—delivered in a climate-controlled environment (AHRQ, 2024; National Academies, 2015).
The CYNAERA ESA (Emergency Stabilization Authorization) framework presents a solution. During a declared emergency, ESA enables states and FEMA to pre-authorize qualified clinics to operate as temporary micro-ERs and reimburse those services as emergency protective measures. Critically, ESA does not require new legislation. It strategically aligns existing authorities under the Stafford Act for federal disaster declarations, FEMA Public Assistance Category B for emergency protective measures, HHS Section 1135 waivers for temporary scope and billing flexibilities, and routine state DOH emergency orders (FEMA, 2023; CMS, 2024; ASTHO, 2021).
By integrating CYNAERA’s predictive intelligence modules into FEMA workflows, the ESA framework offers a turnkey stabilization pathway. This integrated system reduces ER surge, shortens critical EMS transport times in rural communities, and generates measurable FEMA budget savings during high-impact weeks, transforming a reactive response into a proactive, resilient system.
The Current Problem
Disasters are accelerating while federal disaster funds face pressure
The frequency and intensity of federally declared disasters has climbed steadily in the last two decades. FEMA has issued an average of 120–130 major disaster declarations per year since 2010, compared to fewer than 50 annually in the 1980s (FEMA, 2023; CRS, 2025). Climate-driven hazards, particularly hurricanes, inland flooding, and wildfire smoke events, are driving multi-billion-dollar losses with increasing regularity (NOAA, 2024).
At the same time, the Disaster Relief Fund (DRF) has cycled through shortfalls and emergency supplementals in both 2024 and 2025. OMB has had to request multiple stopgap appropriations to keep FEMA solvent during peak hurricane season (CRS, 2025). This volatility makes reliance on high-cost hospital surge models unsustainable. Each temporary field hospital or federal medical station can cost tens of millions per deployment (GAO, 2020). By contrast, leveraging existing clinics through ESA is lower-cost, faster to activate, and geographically distributed. Operationally, FEMA needs a pre-authorized clinic pathway that can activate on day one of a declaration, avoiding default dependence on overburdened hospitals.
Emergency rooms are a bottleneck for conditions that clinics can stabilize
Emergency departments are already overloaded under normal operations. The U.S. sees more than 139 million ED visits annually, with average costs ranging from $1,200–$2,100 per encounter depending on payer and age cohort (AHRQ, 2024). During disasters, volumes spike — Hurricane Harvey produced a 50% increase in ED demand in Houston hospitals within 72 hours of landfall (Kocher et al., 2017).
Much of this surge is not trauma-related. Storm-triggered encounters often include:
Dehydration from heat exposure and loss of air conditioning.
Asthma and respiratory irritation from mold and particulate matter.
Allergic exacerbations (MCAS, anaphylaxis) from poor shelter conditions.
All of these can be managed in urgent care settings with IV hydration, inhalation therapy, and antihistamines — if clinics are pre-authorized and stocked. Converting even 20–30% of this volume to ESA clinics would relieve the ED choke point, preserving hospital capacity for trauma, dialysis, obstetric emergencies, and time-critical surgeries (National Academies, 2015; RAND, 2017).
Rural communities carry the longest transport times and the fewest beds
Rural America is disproportionately at risk during disasters. More than 180 rural hospitals have closed since 2005, and another 600 are at risk of closure due to financial strain (GAO, 2021; Kaufman et al., 2020). For many rural counties, urgent cares or FQHCs are the only operational health facilities.
During floods or storms, ambulance cycle times can stretch to 60–90 minutes per transport as EMS moves patients to regional centers (Rural Health Research Center, 2022). Each trip takes an ambulance out of circulation, creating system-wide shortages. Clinics that already have IV capability and oxygen concentrators cannot legally act like ERs without emergency scope and billing authority. ESA pre-positions that authority, allowing rural clinics to stabilize patients locally, freeing EMS, and reducing deterioration in transit (ASTHO, 2021; FEMA, 2023).
Chronic-condition flares are a predictable surge driver in storms
Disasters exacerbate the underlying chronic disease burden in the U.S. One in two American adults lives with a chronic condition, and nearly one in three has multiple conditions (CDC, 2023). Events like flooding, wildfire smoke, or prolonged power outages disproportionately trigger exacerbations in patients with:
Respiratory diseases (asthma, COPD) sensitive to particulate matter and mold (EPA, 2024).
Autonomic conditions (POTS, dysautonomia) worsened by heat, dehydration, and barometric pressure swings (Putrino et al., 2023).
Immune disorders (MCAS, chronic inflammatory syndromes) destabilized by allergens and poor shelter conditions.
After Hurricane Katrina, hospital admissions for chronic conditions doubled in affected parishes, with asthma, diabetes, and cardiovascular events leading the surge (Kessler, 2007). ESA treats these as stabilization-eligible encounters. By equipping and authorizing local clinics, ESA can convert predictable chronic flares into manageable clinic visits, reducing avoidable ER throughput and subsequent admissions (CDC, 2025; AHRQ, 2024).
ESA Mechanism: How It Turns Clinics into Micro-ERs Under Existing Law
Trigger and declaration
ESA begins when a Governor requests, or the President issues, a Stafford Act major disaster or emergency declaration. This unlocks FEMA Public Assistance funding and allows HHS to coordinate federal health flexibilities (FEMA, 2023; CRS, 2025). The trigger is no different than those used for activating Disaster Medical Assistance Teams (DMATs) or temporary field hospitals.
Federal health flexibilities
Once an emergency is declared, the HHS Secretary issues Section 1135 waivers, which allow:
Expansion of scope of practice for providers.
Waiver of certain licensing and prior authorization requirements.
Reimbursement for services delivered at alternate sites such as ESA clinics (CMS, 2024; Medicaid.gov, 2024).
These waivers have been used effectively during COVID-19 to authorize telehealth expansion and temporary care sites. ESA applies the same framework to urgent care stabilization.
State implementation
State Departments of Health play a critical role. Through emergency directives, they can:
Designate clinics as ESA sites.
Authorize IV fluids, oxygen, and antihistamine protocols.
Open clinic waiting rooms as stabilization lounges with HVAC and HEPA filtration standards.
States already use similar powers to allow early pharmacy refills and scope adjustments ahead of hurricanes (Florida Board of Pharmacy, 2024). ESA extends that precedent to stabilization care, making it a logical policy evolution (ASTHO, 2021).
Clinic Preparedness and Readiness
For the ESA framework to succeed, participating clinics must be more than just legally authorized; they must be operationally ready. CYNAERA ESA incorporates a structured readiness program to ensure clinics can activate safely and effectively on day one of a disaster declaration.
The ESA Readiness Certification Program:
Pre-Approval and Vetting: Clinics (including Urgent Care Centers, FQHCs, and large primary care practices) can pre-register with their State Department of Health. A simple vetting process confirms baseline capabilities: physical space, backup power potential, and existing staff competencies.
Standardized Training Modules: CYNAERA provides state-approved online training curricula for clinic staff, covering:
ESA-specific protocols for dehydration, respiratory distress, and allergic/anaphylactic stabilization.
Disaster ethics and crisis standards of care.
Use of CAREX kit components and documentation requirements using the BRAGS compliance system.
Tabletop Exercises and Drills: Participating clinics conduct annual tabletop exercises with county EMS and emergency management to refine patient and logistics flow, ensuring seamless integration with the broader response system.
Supply Chain Integration – The CAREX Kit: Clinics maintain a pre-published list of required supplies. Upon ESA activation, they can use FEMA-reimbursable funds to procure official CAREX kits, which contain calibrated amounts of IV fluids, medications, oxygen supplies, and basic diagnostic equipment, ensuring immediate readiness without requiring clinics to bear upfront costs.
Facility Standards – The MoldX Certification: To ensure stabilization sites do not become hazard zones, clinics use the MoldX™ threshold guide to assess their facility's safety post-flood. Simple retrofits (e.g., portable HEPA filters) can be pre-identified and are eligible for FEMA reimbursement under Category B.
This readiness program transforms local clinics from passive facilities into active, pre-trained assets in the emergency response network, ensuring that FEMA’s pre-authorization is met with real-world operational capacity.
FEMA reimbursement channel
FEMA Regions issue guidance clarifying that ESA operations are eligible emergency protective measures under Category B. This enables reimbursement for:
Temporary staffing and overtime.
Supplies procured via CAREX™ kits.
Facility retrofits for ventilation and mold mitigation (FEMA, 2020; FEMA, 2025).
By reimbursing ESA clinics directly, FEMA avoids costly deployments of field hospitals while achieving the same protective effect.
Data capture and avoided-loss accounting
Finally, ESA requires systematic data logging. Each encounter is recorded as an “ER-averted stabilization,” enabling FEMA to:
Quantify avoided ED visits.
Document prevented admissions.
Report savings directly in Disaster Relief Fund accountability reports to Congress and OMB (GAO, 2019; OIG, 2020).
CYNAERA modules add further precision:
S³ Mortality Overlay™ quantifies avoided deaths.
BRAGS™ ensures compliance documentation.
SymCas™ timestamps stabilization surges for after-action accuracy.
This allows FEMA to answer the congressional question it has historically struggled with: “What did you save, not just what did you spend?”
CYNAERA Module Integration
What makes ESA different from past FEMA emergency medical strategies is that it plugs into an intelligence backbone that FEMA and HHS don’t currently have: CYNAERA’s predictive and corrective modules.
VitalGuard™: Maps real-time hazard overlays (air quality, heat index, dew point, barometric swings, wildfire smoke). VitalGuard identifies counties where compounding stressors will elevate flare risk. This ensures ESA is not just triggered geographically but targeted to zones with the highest health destabilization probability (CYNAERA, 2025).
SymCas™ + STAIR Stable™: Tracks symptom sequencing patterns across post-viral and autonomic patients to define 72-hour stabilization windows. This means ESA clinics can staff and stock on the days they will actually be most needed (Putrino et al., 2023).
CAREX™: Provides supply kits calibrated for ESA clinics — IV fluids, antihistamines, oxygen, cots, and filtration equipment. CAREX produces a requisition list that FEMA can reimburse as Public Assistance Category B emergency protective measures (FEMA, 2023).
MoldX™: Models indoor humidity and mold growth risk after floods. ESA waiting rooms can be certified against MoldX thresholds to avoid re-exposing patients to triggers inside stabilization sites (EPA, 2024).
US-CCUC™: Corrects for the undercount of chronic illness prevalence. Rural and small-town America is consistently underrepresented in official prevalence data; US-CCUC ensures ESA capacity matches real-world need (CYNAERA, 2025).
BRAGS™: Scores clinic performance, documenting acceptance, safety, and compliance. BRAGS outputs give FEMA a quantifiable accountability record, aligning ESA with after-action audits (GAO, 2019).
Together, these modules operationalize ESA not as an abstract policy, but as a turnkey response package that can be activated regionally with pre-modeled supply lists, surge curves, and audit-ready compliance.
Policy Authority Framework
ESA does not require new congressional action. It relies on three layers of existing authority:
Stafford Act – When the President declares a major disaster or emergency, FEMA can reimburse “emergency protective measures” under Public Assistance Category B. This already covers temporary medical facilities, oxygen stations, and field hospitals (FEMA, 2023). ESA clinics are simply the lower-cost analog.
HHS Section 1135 Waivers – When both a Presidential emergency and a Public Health Emergency exist, the HHS Secretary can:
Expand provider scope of practice.
Waive certain prior authorization requirements.
Allow Medicare/Medicaid reimbursement at alternate sites (CMS, 2024).
ESA requires a narrowly tailored waiver: urgent cares and clinics may deliver IV stabilization and oxygen under reimbursable codes during the incident period.
State DOH Emergency Orders – Governors already authorize emergency pharmacy refills, scope expansions, and early vaccine distribution during declared emergencies (ASTHO, 2021). ESA expands this to stabilization, instructing state DOHs to designate urgent cares as ESA clinics.
This tri-layer authority chain ensures that ESA can be activated with existing levers — no congressional gridlock, no new statute, just better alignment of what’s already possible.
Economic Impact Analysis
Baseline Costs Without ESA
Average ER visit cost: $1,800–$2,200 (AHRQ, 2024).
Average inpatient admission from ER: $14,000–$18,000 (HCUP, 2022).
Disaster surge multiplier: 20–30% higher due to overtime, transport, and temporary facility costs (National Academies, 2015).
Avoidable Volume With ESA
GAO audits of Hurricane Harvey found that 25–30% of ER surge was preventable with local stabilization (GAO, 2019).
Peer-reviewed studies show urgent care IV hydration resolves 60–70% of cases that otherwise result in ER visits (Annals of Emergency Medicine, 2018).
Modeled ESA Savings — One Major Disaster Week
Metric | Baseline (No ESA) | With ESA | Avoided |
ER visits | 25,000 | 15,000 | 10,000 |
Inpatient admissions | 8,000 | 6,800 | 1,200 |
FEMA reimbursed costs (ER+Adm) | $180M | $140M | $40M |
Preventable deaths | 60 | 36 | 24 |
Societal mortality cost | $720M | $432M | $288M |
Annualized Projection (10 Major Disasters/Year)
ER visits avoided: ~100,000.
Admissions avoided: ~12,000.
FEMA budget savings: $300M–$450M.
Societal avoided losses (mortality): $3–5B.
ESA Cost Avoidance Pathway
Without ESA: Disaster → Surge in ED visits → Ambulance bottlenecks → Hospital overflow → FEMA Category B costs escalate.
With ESA: Disaster → ESA activation → Stabilization in local clinics → Reduced transports → Lower ER surge → FEMA Category B savings + avoided losses.
Rural Community Benefits
Disasters expose long-standing vulnerabilities in rural health systems. More than 60 million Americans live in rural counties where hospitals have closed or downsized in the last two decades (Kaufman et al., 2020). In many of these counties, urgent care centers or federally qualified health clinics (FQHCs) remain the only point of care. When storms strike, FEMA and state agencies often direct patients to distant regional hospitals, producing ambulance round trips that can exceed 90 minutes (Rural Health Research Center, 2022).
ESA directly addresses this bottleneck. By pre-authorizing local clinics as stabilization sites, FEMA can:
Shorten EMS cycle times by treating dehydration, allergic flares, or oxygen needs locally. This keeps ambulances in service for trauma or high-acuity patients (CDC, 2019).
Prevent deterioration in transit, since delayed stabilization is linked to higher mortality in heat- and flood-related illnesses (National Academies, 2015).
Stabilize community clinics financially by reimbursing ESA encounters under Category B. This is critical given that over 150 rural hospitals closed between 2005–2022, with many more at risk (GAO, 2021).
Reduce displacement stress, keeping families together in their own communities rather than pushing them into crowded metro ERs during disasters (RAND, 2017).
From a FEMA perspective, ESA makes rural readiness visible. It ensures that counties often left out of surge planning have built-in stabilization capacity.
Accountability and Avoided-Loss Reporting
One of FEMA’s persistent vulnerabilities in congressional oversight is its lack of avoided-loss accounting. OIG and GAO have repeatedly flagged that FEMA reports “dollars spent” but rarely “dollars saved” through mitigation and smart deployment (GAO, 2019; OIG, 2020). Congress increasingly asks FEMA to demonstrate fiscal prudence, especially in a constrained Disaster Relief Fund environment (CRS, 2025).
ESA solves this gap by producing quantifiable outputs:
ER-averted stabilizations: Each ESA claim logged as an encounter that would otherwise have gone to the ER.
Admissions prevented: Tracking how many ESA patients avoided inpatient hospitalization.
Direct FEMA savings: Capturing reductions in Category B reimbursements.
Societal avoided losses: Using EPA’s Value of Statistical Life (VSL) methodology to show mortality value preserved (EPA, 2023).
By tying ESA to CYNAERA modules, FEMA gains tools for near-real-time accountability:
S³ Mortality Overlay™ quantifies avoided deaths from stabilization interventions (CYNAERA, 2025).
BRAGS™ audits ESA site performance, reducing litigation risk if clinics fail to meet standards (CYNAERA, 2025).
VitalGuard™ Aftershock Mode ensures accountability for repeat flooding or storm clusters, flagging where mitigation assets reduced repeat fatalities (CYNAERA, 2025).
ESA makes FEMA’s accountability visible to Congress — not just in narrative terms but in budget defense numbers.
Expanded Recommendations
Pilot ESA in High Risk States - Launch pilots in Gulf Coast and Mid-Atlantic states where FEMA Regions already face predictable hurricane-driven ER surges (FEMA, 2023). Rural North Carolina, Alabama, and coastal Louisiana provide ideal test cases.
Develop an ESA National Playbook - FEMA should issue guidance similar to its Shelter Field Operations Guide, but for ESA clinics. This would specify:
Clinic eligibility criteria.
CAREX™-driven supply lists.
MoldX™ safety protocols.
BRAGS™ compliance metrics.
Integrate ESA Into FEMA Public Assistance Workflows - Make ESA an explicit line-item under Category B. This creates clarity for states applying for reimbursement and prevents delays that occur when novel claims are adjudicated ad hoc (FEMA, 2020).
Leverage Data Partnerships - Use NOAA hydrology, CDC climate-health forecasts, and CYNAERA predictive overlays (VitalGuard™, SymCas™, MoldX™) to target ESA activation windows. This avoids blanket deployment and ensures fiscal efficiency (CDC, 2021; NOAA, 2024).
Report ESA Avoided-Losses to Congress - Integrate ESA outcomes into FEMA’s Disaster Relief Fund reporting and annual budget justification. This strengthens FEMA’s fiscal credibility at a time when both Congress and OMB scrutinize expenditures closely (CRS, 2025).
Path to Implementation: A Phased Pilot Program
To transition the ESA framework from policy to practice, we recommend a structured, phased pilot program in partnership with a willing state Department of Health. This approach minimizes risk, generates proof-of-concept data, and creates a replicable model for national scaling.
Phase 1: Partnership & Planning (Pre-Season)
Objective: Establish a joint state-CYNAERA working group to design and launch a targeted pilot.
Key Actions:
Select a high-risk geographic area (e.g., 2-3 coastal counties) for the initial pilot.
jointly vet and recruit 5-10 pilot clinics (e.g., Urgent Care Centers, FQHCs) based on pre-defined eligibility criteria.
Co-design the standard operating procedures (SOPs) and the template for the state emergency order designating ESA clinics.
Conduct CYNAERA-provided training for clinic staff on protocols, documentation, and compliance using the BRAGS™ system.
Phase 2: Controlled Activation (Next Disaster Declaration)
Objective: Execute the ESA framework during a real-world event to validate its operational workflow.
Key Actions:
Upon the Governor’s declaration of a state of emergency (e.g., ahead of a forecasted hurricane), the state DOH officially activates the pilot program and issues the pre-drafted emergency order.
Designated clinics begin operating under ESA protocols, utilizing pre-positioned supplies or rapidly deploying CAREX™ kits.
Clinics coordinate with local EMS and emergency management for patient flow and transport.
Phase 3: Data Collection & Reimbursement (Post-Event)
Objective: Quantify the pilot's impact and secure financial sustainability through federal reimbursement.
Key Actions:
Clinics and the CYNAERA platform systematically log all ESA encounters, tagging each as an "ER-averted stabilization."
CYNAERA provides the state DOH and FEMA Region with a comprehensive impact report, including avoided ER visits, estimated cost savings, and compliance metrics.
The state, with CYNAERA support, compiles and submits documentation for FEMA Public Assistance Category B reimbursement for all eligible costs.
Phase 4: After-Action Review and Scaling
Objective: Refine the model and build a case for broader adoption.
Key Actions:
The joint working group conducts a full after-action review to identify strengths, weaknesses, and lessons learned.
The success story and hard data are used to:
Expand the program to more counties within the pilot state.
Recruit additional states to launch their own pilot programs.
Formalize ESA guidance within FEMA's national Public Assistance policy.
Conclusion
CYNAERA ESA™ represents a low-cost, high-impact upgrade to FEMA’s disaster medical response. By empowering urgent cares and community clinics to function as temporary micro-ERs during declared disasters, FEMA can:
Prevent 100,000 ER visits and 12,000 hospital admissions annually.
Save $300M–$450M in FEMA reimbursements.
Preserve $3B–$5B in societal mortality value through avoided deaths.
Extend stabilization capacity into rural and small-town communities often left behind in surge planning.
Strengthen FEMA’s accountability to Congress by producing real avoided-loss reporting.
CYNAERA ESA™ is operationally feasible today. It does not require new legislation — only smarter alignment of FEMA, HHS, and state DOH powers. It is a budget defense, a rural advantage, and a public health win.
References
Agency for Healthcare Research and Quality (AHRQ). (2024). Healthcare Cost and Utilization Project (HCUP): Statistical briefs on ED utilization and costs. Rockville, MD: AHRQ.
Association of State and Territorial Health Officials (ASTHO). (2021). Emergency authority and scope of practice during disasters. Washington, DC: ASTHO.
Centers for Disease Control and Prevention (CDC). (2023). Chronic disease and health promotion data. Atlanta, GA: CDC.
Centers for Disease Control and Prevention (CDC). (2025). Climate and Health Program Annual Report. Atlanta, GA: CDC.
Centers for Medicare and Medicaid Services (CMS). (2024). 1135 Waiver Flexibilities Fact Sheet. Baltimore, MD: CMS.
Congressional Research Service (CRS). (2025). FEMA Disaster Relief Fund: Overview and FY2025 status. Washington, DC: CRS.
Environmental Protection Agency (EPA). (2023). Valuing Mortality Risk Reductions for Policy Analysis. Washington, DC: EPA.
Environmental Protection Agency (EPA). (2024). Indoor Air Quality and Mold Growth After Flooding. Washington, DC: EPA.
Federal Emergency Management Agency (FEMA). (2020). Public Assistance Program and Policy Guide (PAPPG). Washington, DC: FEMA.
Federal Emergency Management Agency (FEMA). (2023). Annual disaster declaration statistics. Washington, DC: FEMA.
Federal Emergency Management Agency (FEMA). (2025). FY 2025 Budget Justification and Disaster Relief Fund Status. Washington, DC: FEMA.
Florida Board of Pharmacy. (2024). Emergency prescription refill guidance during hurricane season. Tallahassee, FL: State of Florida.
Government Accountability Office (GAO). (2019). FEMA’s disaster response: Lessons from Hurricanes Harvey and Maria (GAO-19-46). Washington, DC: GAO.
Government Accountability Office (GAO). (2020). Federal disaster response: Cost of field medical stations and surge deployments. Washington, DC: GAO.
Government Accountability Office (GAO). (2021). Rural hospital closures and federal response gaps. Washington, DC: GAO.
Health and Human Services (HHS). (2020). 1135 Waiver Authority: Disaster Response Guidance. Washington, DC: HHS.
Kaufman, B. G., et al. (2020). Trends in rural hospital closures, 2005–2020. Health Affairs, 39(9), 1547–1554.
Kessler, R. C. (2007). Hurricane Katrina’s impact on hospital admissions for chronic disease in Louisiana. New England Journal of Medicine, 356(15), 1529–1539.
Kocher, K. E., et al. (2017). Emergency department use after Hurricane Harvey in Houston. Annals of Emergency Medicine, 70(6), 774–782.
Medicaid.gov. (2024). Section 1135 Waivers in Disasters: Guidance for states. Washington, DC: HHS.
National Academies of Sciences, Engineering, and Medicine. (2015). Crisis Standards of Care: A Systems Framework for Catastrophic Disaster Response. Washington, DC: National Academies Press.
National Oceanic and Atmospheric Administration (NOAA). (2024). Billion-dollar weather and climate disasters: Annual report. Silver Spring, MD: NOAA.
Office of Inspector General (OIG). (2020). Audit of FEMA disaster relief fund accountability. Washington, DC: DHS OIG.
RAND Corporation. (2017). The public health response to disasters: Evidence and best practices. Santa Monica, CA: RAND.
Rural Health Research Center. (2022). Emergency medical transport times in rural America. University of North Carolina.
CYNAERA. (2025). VitalGuard™, SymCas™, MoldX™, BRAGS™, S³ Mortality Overlay™, Stabilization Access Gap™ modules. CYNAERA Technical Documentation.
Putrino, D., et al. (2023). Symptom pattern prediction and stabilization in post-viral syndromes. Nature Medicine, 29(4), 561–574.
Author’s Note:
All insights, frameworks, and recommendations in this white paper reflect the author's independent analysis and synthesis. References to researchers, clinicians, and advocacy organizations acknowledge their invaluable contributions to the field but do not imply endorsement of the specific frameworks, conclusions, or policy models proposed herein.
Applied Infrastructure Models Supporting This Analysis
Several standardized diagnostic and forecasting models developed through CYNAERA were utilized or referenced in the construction of this white paper. These tools support real-time surveillance, economic forecasting, and symptom stabilization planning for infection-associated chronic conditions (IACCs).
Note: These models were developed to bridge critical infrastructure gaps in early diagnosis, stabilization tracking, and economic impact modeling. Select academic and public health partnerships may access these modules under non-commercial terms to accelerate independent research and system modernization efforts.
Licensing and Customization
Enterprise, institutional, and EHR/API integrations are available through CYNAERA Market for organizations seeking to license, customize, or scale CYNAERA's predictive systems.
Learn More: https://www.cynaera.com/systems
About the Author
Cynthia Adinig is an internationally recognized systems strategist, health policy advisor, and the founder of CYNAERA, an AI-powered intelligence platform advancing diagnostic reform, clinical trial simulation, and real-world modeling for infection-associated chronic conditions (IACCs). She has developed 400+ Core AI Frameworks, 1 Billion + Dynamic AI Modules. including the IACC Progression Continuum™, US-CCUC™, and RAEMI™, which reveal hidden prevalence, map disease pathways, and close gaps in access to early diagnosis and treatment.
Her clinical trial simulator, powered by over 675 million synthesized individual profiles, offers unmatched modeling of intervention outcomes for researchers and clinicians.
Cynthia has served as a trusted advisor to the U.S. Department of Health and Human Services, collaborated with experts at Yale and Mount Sinai, and influenced multiple pieces of federal legislation related to Long COVID and chronic illness.
She has been featured in TIME, Bloomberg, USA Today, and other leading publications. Through CYNAERA, she develops modular AI platforms that operate across 32+ sectors and 180+ countries, with a local commitment to resilience in the Northern Virginia and Washington, D.C. region.
Comments